Harry Crijns

Professor

Harry Crijns is professor and chair of Cardiology and board member of the Cardiovascular Research Institute Maastricht (CARIM) at Maastricht UMC+. He studied medicine at the University of Amsterdam and was trained in cardiology and electrophysiology in Groningen and Maastricht. He is a Fellow of the ESC and a past board member of the EHRA. He is also past Chair of the Netherlands Society of Cardiology. He served on several guidelines committees for the management of AF. Currently he is the chairman of the scientific advisory board of the Dutch Heart Foundation.

His primary research focus continues to be atrial fibrillation (AF). He founded the RACE trials in the Netherlands and led the Euro Heart Survey on AF (ESC). He has established his reputation by introducing innovative concepts for diagnosis and treatment of AF by showing that - quite contrary to longstanding beliefs - electrical management does not change prognosis. This revolutionised management of the arrhythmia worldwide with the effect that major interventions like electrical cardioversion, catheter ablation and antiarrhythmic drug therapy are applied in a much more personalized fashion.

Subsequently his group showed that rate control in AF can be individualized thereby removing the previously used strict heart rate targets from the international guidelines. He also performed the Euro Heart Survey on AF and made many contributions to the field of stroke management in AF, such as the construction of well-recognised AF specific risk stratification scores for AF progression (HATCH), ischemic stroke (CHA2DS2-VASc) and major bleeding (HAS-BLED). These scores have practically conquered the medical AF community and improved patient care whilst boosting new clinical research throughout the world.

His research group now focusses on recent-onset AF, hybrid AF ablation, upstream therapy and vascular mechanisms for AF progression and stroke in idiopathic atrial fibrillation. He is (co-)author on over 650 scientific articles, with 56,677 citations and Hirsch-index of 100.

Department of Cardiology
P. Debyelaan 25, 6229 HX Maastricht 
PO Box 5800, 6202 AZ Maastricht


  • 2021
    • Pluymaekers, N. A. H. A., van der Velden, R. M. J., Hermans, A. N. L., Gawalko, M., Buskes, S., Keijenberg, J. J. H. M. W., Vorstermans, B., Crijns, H. J. G. M., Hendriks, J. M., & Linz, D. (2021). On-Demand Mobile Health Infrastructure for Remote Rhythm Monitoring within a Wait-and-See Strategy for Recent-Onset Atrial Fibrillation: TeleWAS-AF. Cardiology, 146(3), 392-396. https://doi.org/10.1159/000514156
    • Gilbers, M. D., Bidar, E., Maesen, B., Zeemering, S., Isaacs, A., Crijns, H., van Gelder, I., Rienstra, M., Verheule, S., Maessen, J., Stoll, M., & Schotten, U. (2021). Reappraisal of Atrial fibrillation: interaction between hyperCoagulability, Electrical remodelling and Vascular destabilisation in the progression of AF (RACE V) Tissue Bank Project: study design. Netherlands Heart Journal, 29(5), 280-287. https://doi.org/10.1007/s12471-021-01538-x
    • Hermans, A. N. L., Gawalko, M., Pluymaekers, N. A. H. A., Dinh, T., Weijs, B., van Mourik, M. J. W., Vorstermans, B., den Uijl, D. W., Opsteyn, L., Snippe, H., Vernooy, K., Crijns, H. J. G. M., Linz, D., & Luermans, J. G. L. M. (2021). Long-term intermittent versus short continuous heart rhythm monitoring for the detection of atrial fibrillation recurrences after catheter ablation. International Journal of Cardiology, 329, 105-112. https://doi.org/10.1016/j.ijcard.2020.12.077
    • van Rosmalen, F., Delhaas, T., Dagres, N., Arbelo, E., Blomstrom-Lundqvist, C., Crijns, H. J. G. M., Da Costa, A., Pytkowski, M., Sharikov, N., Laroche, C., Tavazzi, L., Brugada, J., Pison, L., & ESC-EHRA Atrial Fibrillation Ablation Long-Term Registry investigators (2021). Adenosine usage during AF ablation in Europe and selected long-term findings from the ESC-EHRA EORP Atrial Fibrillation Ablation Long-Term registry. Journal of Interventional Cardiac Electrophysiology, 60(3), 395-406. https://doi.org/10.1007/s10840-020-00744-8
    • Nedios, S., Sanatkhani, S., Oladosu, M., Seewoester, T., Richter, S., Arya, A., Heijman, J., Crijns, H. J. G. M., Hindricks, G., Bollmann, A., & Menon, P. G. (2021). Association of low-voltage areas with the regional wall deformation and the left atrial shape in patients with atrial fibrillation: A proof of concept study. IJC Heart & Vasculature, 33, Article 100730. https://doi.org/10.1016/j.ijcha.2021.100730
    • van Cauteren, Y. J. M., Smulders, M. W., Theunissen, R. A. L. J., Gerretsen, S. C., Adriaans, B. P., Bijvoet, G. P., Mingels, A. M. A., van Kuijk, S. M. J., Schalla, S., Crijns, H. J. G. M., Kim, R. J., Wildberger, J. E., Heijman, J., & Bekkers, S. C. A. M. (2021). Cardiovascular magnetic resonance accurately detects obstructive coronary artery disease in suspected non-ST elevation myocardial infarction: a sub-analysis of the CARMENTA Trial. Journal of Cardiovascular Magnetic Resonance, 23(1), Article 40. https://doi.org/10.1186/s12968-021-00723-6
    • de Vries, T. A. C., Hemels, M. E. W., Cools, F., Crijns, H. J. G. M., Yperzeele, L., Vanacker, P., Blankoff, I., Lancellotti, P., Mairesse, G. H., de Veer, A., Arroyo, R. C., Catez, E., de Pauw, M., Vanassche, T., de Asmundis, C., Kirchhof, P., De Caterina, R., de Groot, J. R., & ETNA-AF-Europe principal investigators from Belgium and the Netherlands (2021). Characteristics of patients with atrial fibrillation prescribed edoxaban in Belgium and the Netherlands: insights from the ETNA-AF-Europe study. Netherlands Heart Journal, 29(3), 158-167. https://doi.org/10.1007/s12471-020-01518-7
    • Lyon, A., van Mourik, M., Cruts, L., Heijman, J., Bekkers, S. C. A. M., Schotten, U., Crijns, H. J. G. M., Linz, D., & Lumens, J. (2021). Both beat-to-beat changes in RR-interval and left ventricular filling time determine ventricular function during atrial fibrillation. EP Europace, 23, I21-I28. https://doi.org/10.1093/europace/euaa387
    • Fabritz, L., Crijns, H. J. G. M., Guasch, E., Goette, A., Häusler, K. G., Kotecha, D., Lewalter, T., Meyer, C., Potpara, T. S., Rienstra, M., Schnabel, R. B., Willems, S., Breithardt, G., Camm, A. J., Chan, A., Chua, W., de Melis, M., Dimopoulou, C., Dobrev, D., ... Kirchhof, P. (2021). Dynamic risk assessment to improve quality of care in patients with atrial fibrillation: the 7th AFNET/EHRA Consensus Conference. EP Europace, 23(3), 329-344. https://doi.org/10.1093/europace/euaa279
    • Pluymaekers, N. A. H. A., Hermans, A. N. L., van der Velden, R. M. J., Gawalko, M., den Uijl, D. W., Buskes, S., Vernooy, K., Crijns, H. J. G. M., Hendriks, J. M., & Linz, D. (2021). Implementation of an on-demand app-based heart rate and rhythm monitoring infrastructure for the management of atrial fibrillation through teleconsultation: TeleCheck-AF. EP Europace, 23(3), 345-352. https://doi.org/10.1093/europace/euaa201
    • Hermans, B. J. M., Zink, M. D., van Rosmalen, F., Crijns, H. J. G. M., Vernooy, K., Postema, P., Pison, L., Schotten, U., & Delhaas, T. (2021). Pulmonary vein isolation in a real-world population does not influence QTc interval. EP Europace, 23, I48-I54. https://doi.org/10.1093/europace/euaa390
    • Heijman, J., Luermans, J. G. L. M., Linz, D., van Gelder, I. C., & Crijns, H. J. G. M. (2021). Risk Factors for Atrial Fibrillation Progression. Cardiac Electrophysiology Clinics, 13(1), 201-209. https://doi.org/10.1016/j.ccep.2020.10.011
    • Simons, S. O., Elliott, A., Sastry, M., Hendriks, J. M., Arzt, M., Rienstra, M., Kalman, J. M., Heidbuchel, H., Nattel, S., Wesseling, G., Schotten, U., van Gelder, I. C., Franssen, F. M. E., Sanders, P., Crijns, H. J. G. M., & Linz, D. (2021). Chronic obstructive pulmonary disease and atrial fibrillation an interdisciplinary perspective. European Heart Journal, 42(5), 532-540. https://doi.org/10.1093/eurheartj/ehaa822
    • Linde, C., & Crijns, H. J. G. M. (2021). Pacing for repeated vagal reflex-mediated syncope: an old problem with a solution. European Heart Journal, 42(5), 517-519. https://doi.org/10.1093/eurheartj/ehaa975
    • Crijns, H. J. G. M., Prinzen, F., Lambiase, P. D., Sanders, P., & Brugada, J. (2021). The year in cardiovascular medicine 2020: arrhythmias. European Heart Journal, 42(5), 499-507. https://doi.org/10.1093/eurheartj/ehaa1091
    • Benjamin, E. J., Go, A. S., Desvigne-Nickens, P., Anderson, C. D., Casadei, B., Chen, L. Y., Crijns, H. J. G. M., Freedman, B., Hills, M. T., Healey, J. S., Kamel, H., Kim, D.-Y., Link, M. S., Lopes, R. D., Lubitz, S. A., McManus, D. D., Noseworthy, P. A., Perez, M., Piccini, J. P., ... Al-Khatib, S. M. (2021). Research Priorities in Atrial Fibrillation Screening: A Report From a National Heart, Lung, and Blood Institute Virtual Workshop. Circulation, 143(4), 372-388. https://doi.org/10.1161/circulationaha.120.047633
    • Spoormans, E. M., Lemkes, J. S., Janssens, G. N., van der Hoeven, N. W., Jewbali, L. S. D., Dubois, E. A., van de Ven, P. M., Meuwissen, M., Rijpstra, T. A., Bosker, H. A., Blans, M. J., Bleeker, G. B., Baak, R., Vlachojannis, G. J., Eikemans, B. J. W., van der Harst, P., van der Horst, I. C. C., Voskuil, M., van der Heijden, J. J., ... van Royen, N. (2021). Sex differences in patients with out-of-hospital cardiac arrest without ST-segment elevation: A COACT trial substudy. Resuscitation, 158, 14-22. https://doi.org/10.1016/j.resuscitation.2020.10.026
    • Nedios, S., Loebe, S., Knopp, H., Seewoester, T., Heijman, J., Crijns, H. J. G. M., Arya, A., Bollmann, A., Hindricks, G., & Dinov, B. (2021). Left atrial activation and asymmetric anatomical remodeling in patients with atrial fibrillation: The relation between anatomy and function. Clinical Cardiology, 44(1), 116-122. Article 23515. https://doi.org/10.1002/clc.23515
  • 2020
    • Dudink, E. A. M. P., Weijs, B., Luermans, J. G. L. M., Peeters, F. E. C. M., Altintas, S., Vernooy, K., Pison, L. A. F. G., Haest, R. J., Kragten, J. A., Kietselaer, B. L. J. H., Wildberger, J. E., & Crijns, H. J. G. M. (2020). Concealed Coronary Atherosclerosis In Idiopathic Paroxysmal Atrial Fibrillation is Associated with Imminent Cardiovascular Diseases. Journal of Atrial Fibrillation, 13(4), 51-56. https://doi.org/10.4022/jafib.2321
    • Nguyen, B. O., Wijtvliet, E. P. J. P., Hobbelt, A. H., De Vries, S. I. M., Smit, M. D., Tieleman, R. G., Van Veldhuisen, D. J., Crijns, H. J. G. M., Van Gelder, I. C., Rienstra, M., & RACE 3 Investigators (2020). Effects of a simple cardiac rehabilitation program on improvement of self-reported physical activity in atrial fibrillation - Data from the RACE 3 study. IJC Heart and Vasculature, 31, Article 100673. https://doi.org/10.1016/j.ijcha.2020.100673
    • Lemkes, J. S., Janssens, G. N., van der Hoeven, N. W., Jewbali, L. S. D., Dubois, E. A., Meuwissen, M. M., Rijpstra, T. A., Bosker, H. A., Blans, M. J., Bleeker, G. B., Baak, R. R., Vlachojannis, G. J., Eikemans, B. J. W., van der Harst, P., van der Horst, I. C. C., Voskuil, M., van der Heijden, J. J., Beishuizen, A., Stoel, M., ... van Royen, N. (2020). Coronary Angiography After Cardiac Arrest Without ST Segment Elevation: One-Year Outcomes of the COACT Randomized Clinical Trial. JAMA Cardiology, 5(12), 1358-1365. https://doi.org/10.1001/jamacardio.2020.3670
    • Spoormans, E. M., Lemkes, J. S., Janssens, G. N., van der Hoeven, N. W., Jewbali, L. S. D., Dubois, E. A., van de Ven, P. M., Meuwissen, M., Rijpstra, T. A., Bosker, H. A., Blans, M. J., Bleeker, G. B., Baak, R., Vlachojannis, G. J., Eikemans, B. J. W., van der Harst, P., van der Horst, I. C., Voskuil, M., van der Heijden, J. J., ... van Royen, N. (2020). Data on sex differences in one-year outcomes of out-of-hospital cardiac arrest patients without ST-segment elevation. Data in brief, 33, Article 106521. https://doi.org/10.1016/j.dib.2020.106521
    • van den Berg, V. J., Umans, V. A. W. M., Brankovic, M., Oemrawsingh, R. M., Asselbergs, F. W., van der Harst, P., Hoefer, I. E., Kietselaer, B., Crijns, H. J. G. M., Lenderink, T., Ophuis, A. J. O., van Schaik, R. H., Kardys, I., Boersma, E., Akkerhuis, K. M., & BIOMArCS Investigators (2020). Stabilization patterns and variability of hs-CRP, NT-proBNP and ST2 during 1 year after acute coronary syndrome admission: results of the BIOMArCS study. Clinical Chemistry and Laboratory Medicine, 58(12), 2099-2106. https://doi.org/10.1515/cclm-2019-1320
    • Verdonschot, J. A. J., Merken, J. J., van Stipdonk, A. M. W., Pliger, P., Derks, K. W. J., Wang, P., Henkens, M. T. H. M., van Paassen, P., Hamid, M. A. A., van Empel, V. P. M., Knackstedt, C., Luermans, J. G. L. M., Crijns, H. J. G. M., Brunner-La Rocca, H.-P., Brunner, H. G., Poelzl, G., Vernooy, K., Heymans, S. R. B., & Hazebroek, M. R. (2020). Cardiac Inflammation Impedes Response to Cardiac Resynchronization Therapy in Patients With Idiopathic Dilated Cardiomyopathy. Circulation-Arrhythmia and Electrophysiology, 13(11), 1311-1320. Article 008727. https://doi.org/10.1161/circep.120.008727
    • Hermans, A. N. L., van der Velden, R. M. J., Gawalko, M., Verhaert, D. V. M., Desteghe, L., Duncker, D., Manninger, M., Heidbuchel, H., Pisters, R., Hemels, M., Pison, L., Sohaib, A., Sultan, A., Steven, D., Wijtvliet, P., Tieleman, R., Gupta, D., Dobrev, D., Svennberg, E., ... TeleCheck-AF investigators (2020). On-demand mobile health infrastructures to allow comprehensive remote atrial fibrillation and risk factor management through teleconsultation. Clinical Cardiology, 43(11), 1232-1239. https://doi.org/10.1002/clc.23469
    • Kloosterman, M., Crijns, H. J. G. M., Mulder, B. A., Groenveld, H. F., Van Veldhuisen, D. J., Rienstra, M., & Van Gelder, I. C. (2020). Sex-related differences in risk factors, outcome, and quality of life in patients with permanent atrial fibrillation: results from the RACE II study. EP Europace, 22(11), 1619-1627. https://doi.org/10.1093/europace/euz300
    • Kirchhof, P., Camm, A. J., Goette, A., Brandes, A., Eckardt, L., Elvan, A., Fetsch, T., van Gelder, I. C., Haase, D., Haegeli, L. M., Hamann, F., Heidbuchel, H., Hindricks, G., Kautzner, J., Kuck, K. H., Mont, L., Ng, G. A., Rekosz, J., Schoen, N., ... EAST-AFNET 4 Trial Investigators (2020). Early Rhythm-Control Therapy in Patients with Atrial Fibrillation. New England Journal of Medicine, 383(14), 1305-1316. https://doi.org/10.1056/NEJMoa2019422
    • Brandes, A., Crijns, H. J. G. M., Rienstra, M., Kirchhof, P., Grove, E. L., Pedersen, K. B., & Van Gelder, I. C. (2020). Electrical cardioversion of atrial fibrillation and atrial flutter: manoeuvres and tips to increase its effectiveness-Authors' reply. EP Europace, 22(10), 1602-1602. https://doi.org/10.1093/europace/euaa212
    • Bogossian, H., Linz, D., Heijman, J., Bimpong-Buta, N.-Y., Bandorski, D., Frommeyer, G., Erkapic, D., Seyfarth, M., Zarse, M., & Crijns, H. J. (2020). QTc evaluation in patients with bundle branch block. IJC Heart & Vasculature, 30, Article 100636. https://doi.org/10.1016/j.ijcha.2020.100636
    • Pluymaekers, N. A. H. A., Linz, D. K., Rienstra, M., van Gelder, I. C., & Crijns, H. J. G. M. (2020). Emergency department cardioversion of acute atrial fibrillation. Lancet, 396(10255), 884-885. https://doi.org/10.1016/S0140-6736(20)31311-8
    • Bonizzi, P., Meste, O., Zeemering, S., Karel, J., Lankveld, T., Crijns, H., Schotten, U., & Peeters, R. (2020). A novel framework for noninvasive analysis of short-term atrial activity dynamics during persistent atrial fibrillation. Medical & Biological Engineering & Computing, 58(9), 1933-1945. https://doi.org/10.1007/s11517-020-02190-0
    • van der Velden, R. M. J., Hermans, A. N. L., Pluymaekers, N. A. H. A., Gawalko, M., Vorstermans, B., Martens, H., Buskes, S., Crijns, H. J. G. M., Linz, D., & Hendriks, J. M. (2020). Coordination of a remote mHealth infrastructure for atrial fibrillation management during COVID-19 and beyond: TeleCheck-AF. International Journal of Care Coordination, 23(2-3), 65-70. Article 2053434520954619. https://doi.org/10.1177/2053434520954619
    • Lyon, A., Dupuis, L. J., Arts, T., Crijns, H. J. G. M., Prinzen, F. W., Delhaas, T., Heijman, J., & Lumens, J. (2020). Differentiating the effects of β-adrenergic stimulation and stretch on calcium and force dynamics using a novel electromechanical cardiomyocyte model. American Journal of Physiology-heart and Circulatory Physiology, 319(3), H519-H530. https://doi.org/10.1152/ajpheart.00275.2020
    • Erkapic, D., Frommeyer, G., Brettner, N., Soezener, K., Crijns, H. J. G. M., Seyfarth, M., Hamm, C. W., & Bogossian, H. (2020). QTc interval evaluation in patients with right bundle branch block or bifascicular blocks. Clinical Cardiology, 43(9), 957-962. https://doi.org/10.1002/clc.23389
    • Nguyen, B. O., Rienstra, M., Hobbelt, A. H., Tijssen, J. G. P., Smit, M. D., Tieleman, R. G., Geelhoed, B., Van Veldhuisen, D. J., Crijns, H. J. G. M., Van Gelder, I. C., & RACE 3 Investigators (2020). Optimal treatment of underlying conditions improves rhythm control outcome in atrial fibrillation - Data from RACE 3. American Heart Journal, 226, 235-239. https://doi.org/10.1016/j.ahj.2019.12.005
    • Brandes, A., Crijns, H. J. G. M., Rienstra, M., Kirchhof, P., Grove, E. L., Pedersen, K. B., & Van Gelder, I. C. (2020). Cardioversion of atrial fibrillation and atrial flutter revisited: current evidence and practical guidance for a common procedure. EP Europace, 22(8), 1149-1161. https://doi.org/10.1093/europace/euaa057
    • Chu, G., Seelig, J., Trinks-Roerdink, E. M., van Alem, A. P., Alings, M., van den Bemt, B., Boersma, L. V. A., Brouwer, M. A., Cannegieter, S. C., ten Cate, H., Kirchhof, C. J. H. J., Crijns, H. J. G. M., van Dijk, E. J., Elvan, A., van Gelder, I. C., de Groot, J. R., den Hartog, F. R., de Jong, J. S. S. G., de Jong, S., ... Huisman, M. (2020). Design and rationale of DUTCH-AF: a prospective nationwide registry programme and observational study on long-term oral antithrombotic treatment in patients with atrial fibrillation. BMJ Open, 10(8), Article 036220. https://doi.org/10.1136/bmjopen-2019-036220
    • Crijns, H. J. G. M., & Van Gelder, I. C. (2020). Paradigm shifts in pathophysiology and management of atrial fibrillation-a tale of the RACE trials in the Netherlands. Netherlands Heart Journal, 28(SUPPL 1), 3-12. https://doi.org/10.1007/s12471-020-01476-0
    • De With, R. R., Erkuner, O., Rienstra, M., Nguyen, B.-O., Korver, F. W. J., Linz, D., Ten, H. C., Spronk, H., Kroon, A. A., Maass, A. H., Blaauw, Y., Tieleman, R. G., Hemels, M. E. W., de Groot, J. R., Elvan, A., de Melis, M., Scheerder, C. O. S., Al-Jazairi, M. I. H., Schotten, U., ... RACE V Investigators (2020). Temporal patterns and short-term progression of paroxysmal atrial fibrillation data from RACE V. EP Europace, 22(8), 1162-1172. https://doi.org/10.1093/europace/euaa123
    • Peeters, F. E. C. M., Dudink, E. A. M. P., Weijs, B., Fabritz, L., Chua, W., Kietselaer, B. L. J. H., Wildberger, J. E., Meex, S. J. R., Kirchhof, P., Crijns, H. J. G. M., & Schurgers, L. J. (2020). Biomarkers Associated With Aortic Valve Calcification: Should We Focus on Sex Specific Processes?Frontiers in Cell and Developmental Biology, 8, Article 604. https://doi.org/10.3389/fcell.2020.00604
    • van der Nat, P. B., van Veghel, D., Daeter, E., Crijns, H. J., Koolen, J., Houterman, S., Soliman, M. A., de Mol, B. A., & Meetbaar Beter Study Group (2020). Insights on value-based healthcare implementation from Dutch heart care. International Journal of Healthcare Management, 13(3), 189-192. https://doi.org/10.1080/20479700.2017.1397307
    • de With, R. R., Rienstra, M., Crijns, H. J. G. M., Van Gelder, I. C., & RACE 3 Investigators (2020). Determinants of sinus rhythm maintenance in patients with early-persistent atrial fibrillation and heart failure. Clinical research in cardiology, 109(6), 787-789. https://doi.org/10.1007/s00392-019-01581-0
    • Heuts, S., Adriaans, B. P., Rylski, B., Mihl, C., Bekkers, S. C. A. M., Olsthoorn, J. R., Natour, E., Bouman, H., Berezowski, M., Kosiorowska, K., Crijns, H. J. G. M., Maessen, J. G., Wildberger, J., Schalla, S., & Sardari Nia, P. (2020). Evaluating the diagnostic accuracy of maximal aortic diameter, length and volume for prediction of aortic dissection. Heart, 106(12), 892-897. https://doi.org/10.1136/heartjnl-2019-316251
    • Pluymaekers, N. A. H. A., Hermans, A. N. L., van der Velden, R. M. J., den Uijl, D. W., Vorstermans, B., Buskes, S., Hendriks, J. M., Vernooy, K., Crijns, H. J. G. M., & Linz, D. (2020). On-demand app-based rate and rhythm monitoring to manage atrial fibrillation through teleconsultations during COVID-19. IJC Heart & Vasculature, 28, Article 100533. https://doi.org/10.1016/j.ijcha.2020.100533
    • Smedema, J. P., Ainslie, G., & Crijns, H. J. G. M. (2020). Review: Contrast-enhanced magnetic resonance in the diagnosis and management of cardiac sarcoidosis. Progress in Cardiovascular Diseases, 63(3), 271-307. https://doi.org/10.1016/j.pcad.2020.03.011
    • Coopmans, C., Zhou, T. L., Henry, R. M. A., Heijman, J., Schaper, N. C., Koster, A., Schram, M. T., van der Kallen, C. J. H., Wesselius, A., den Engelsman, R. J. A., Crijns, H. J. G. M., & Stehouwer, C. D. A. (2020). Both Prediabetes and Type 2 Diabetes Are Associated With Lower Heart Rate Variability: The Maastricht Study. Diabetes Care, 43(5), 1126-1133. https://doi.org/10.2337/dc19-2367
    • Haanschoten, D. M., Elvan, A., Postema, P. G., Smit, J. J. J., Adiyaman, A., Ter Bekke, R. M. A., Asaad, N., Aanhaanen, W. T. J., Misier, A. R. R., Delnoy, P. P. H. M., Crijns, H. J. G. M., & Wilde, A. A. M. (2020). Catheter ablation in highly symptomatic Brugada patients: a Dutch case series. Clinical research in cardiology, 109(5), 560-569. https://doi.org/10.1007/s00392-019-01540-9
    • Thind, M., Crijns, H. J., Naccarelli, G. V., Reiffel, J. A., Corp Dit Genti, V., Wieloch, M., Koren, A., & Kowey, P. R. (2020). Dronedarone treatment following cardioversion in patients with atrial fibrillation/flutter: A post hoc analysis of the EURIDIS and ADONIS trials. Journal of Cardiovascular Electrophysiology, 31(5), 1022-1030. https://doi.org/10.1111/jce.14405
    • Crijns, H. J. G. M., Wijtvliet, E. P. J., Pluymaekers, N. A. H. A., & Van Gelder, I. C. (2020). Newly discovered atrial fibrillation: who(se) care(s)?EP Europace, 22(5), 677-678. https://doi.org/10.1093/europace/euz359